Funding for this research was provided by:
National Natural Science Foundation of China (81101996)
Health and Family Planning Commission of Hunan Province (B20180416)
The Planned Science and Technology Project of Hunan Province (2014FJ2015)
Chinese Anti-Cancer Association (29)
Medical Technology Innovation Guidance Project from Department of Science and Technology of Hunan Province (2017SK50604)
Received: 15 February 2020
Accepted: 10 May 2020
First Online: 19 May 2020
Ethics approval and consent to participate
: The study was approved by the Hunan Cancer Hospital/the Affiliated Tumor Hospital of Xiangya School of Medicine, Central South University Institutional Ethics Committee (Number KYJJ-2018-035). Informed consent was obtained from all patients prior to analysis. All animals experimental methods involved in this study are in line with the Helsinki Declaration and approved by the Institutional Animal Care and Use Committee of the Affiliated Tumor Hospital of Xiangya School of Medicine, Central South University.
: Not applicable.
: The authors declare that they have no significant competing financial, professional, or personal interests that might have influenced the performance or presentation of the work described in this manuscript.